Workflow
Earnings Surprise
icon
Search documents
VAREX IMAGING (VREX) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2025-05-08 23:30
Group 1 - VAREX IMAGING reported $212.9 million in revenue for the quarter ended March 2025, a year-over-year increase of 3.3% [1] - The EPS for the same period was $0.26, compared to $0.16 a year ago, indicating a significant improvement [1] - The reported revenue exceeded the Zacks Consensus Estimate of $206.83 million by 2.93%, and the EPS surprised by 85.71% against the consensus estimate of $0.14 [1] Group 2 - VAREX IMAGING's Industrial revenues were $59.10 million, slightly below the estimated $59.12 million, reflecting a 3% year-over-year change [4] - Medical revenues reached $153.80 million, surpassing the average estimate of $147.36 million, marking a 3.4% increase year-over-year [4] - Gross profit for Industrial was $20.80 million, exceeding the estimated $19.64 million, while Medical gross profit was $55.90 million, above the estimated $48.61 million [4] Group 3 - VAREX IMAGING shares have returned -6% over the past month, contrasting with the Zacks S&P 500 composite's +11.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]
10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-05-08 22:56
Company Performance - 10x Genomics reported a quarterly loss of $0.36 per share, better than the Zacks Consensus Estimate of a loss of $0.45, and an improvement from a loss of $0.50 per share a year ago, representing an earnings surprise of 20% [1] - The company posted revenues of $154.88 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 16.24%, and up from $141.01 million in the same quarter last year [2] - Over the last four quarters, 10x Genomics has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Performance - 10x Genomics shares have declined approximately 42.1% since the beginning of the year, compared to a decline of 4.3% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -$0.37 on revenues of $146.51 million, and for the current fiscal year, it is -$1.47 on revenues of $609.56 million [7] Industry Outlook - The Medical Info Systems industry, to which 10x Genomics belongs, is currently ranked in the top 32% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - The performance of 10x Genomics may be influenced by the overall industry outlook, as empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions [5][8]
Paramount Global-B (PARA) Q1 Earnings and Revenues Surpass Estimates
ZACKS· 2025-05-08 22:20
Paramount Global-B (PARA) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.62 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.41%. A quarter ago, it was expected that this company would post earnings of $0.10 per share when it actually produced a loss of $0.11, delivering a surprise of -210%.Over the last four quarters, the company h ...
Plains All American to Report Q1 Earnings: How to Play the Stock?
ZACKS· 2025-05-08 18:50
Core Viewpoint - Plains All American Pipeline, L.P. (PAA) is anticipated to show improvements in both revenue and earnings for the first quarter of 2025, with revenues expected to reach $13.12 billion, reflecting a 9.35% increase year-over-year, and earnings estimated at 43 cents per unit, indicating a 4.88% increase from the previous year [1][2]. Financial Performance - The Zacks Consensus Estimate for PAA's first-quarter revenues is $13.12 billion, which is a 9.35% increase from the same quarter last year [1]. - The consensus estimate for earnings is 43 cents per unit, representing a 4.88% increase from the year-ago figure [2]. - PAA has a mixed surprise history, missing earnings estimates in two of the last four quarters while surpassing in the other two, resulting in an average positive surprise of 3.47% [3][4]. Earnings Prediction - The current Earnings ESP for PAA is -4.05%, indicating that the model does not predict a likely earnings beat this time [5]. - PAA's Zacks Rank is 3 (Hold), which does not suggest a strong likelihood of an earnings surprise compared to other companies in the sector [6]. Operational Factors - PAA operates a vast network of pipelines and storage facilities in key North American oil-producing regions, which is crucial for the efficient transportation of crude oil and is expected to positively impact earnings [8]. - A significant portion of PAA's cash flow comes from fee-based contracts, providing stable income streams that are less affected by short-term oil price fluctuations [9]. - Recent bolt-on acquisitions have expanded PAA's pipeline operations, contributing positively to earnings through operational synergies [10]. - The company has focused on reducing debt levels and enhancing operational efficiency, leading to improved margins [11]. Market Position - PAA's current trailing 12-month EV/EBITDA is 8.8X, which is lower than the industry average of 11.4X, indicating that the stock is trading at a discount [12]. - Over the past six months, PAA's units have declined by 1.6%, which is better than the industry's 8.2% loss [14]. Investment Outlook - PAA is positioned as a leading midstream energy company with a strategically located network that plays a vital role in linking upstream producers with downstream markets [15]. - The company benefits from long-term, fee-based contracts that ensure stable earnings and reduce exposure to commodity price fluctuations [16]. - Future performance is expected to be driven by strategic joint ventures, ongoing debt reduction, and a strong presence in the Permian Basin [18].
Crocs Beats Q1 Earnings & Revenue Estimates, Withdraws 2025 View
ZACKS· 2025-05-08 17:40
Core Insights - Crocs, Inc. reported strong first-quarter 2025 results, with revenues and earnings surpassing the Zacks Consensus Estimate, driven by effective execution across Crocs and HEYDUDE brands, disciplined cost management, resilient consumer demand, and strategic pricing [1][2] Financial Performance - Adjusted earnings per share were $3.00, beating the Zacks Consensus Estimate of $2.51, remaining nearly flat year over year [4] - Consolidated revenues were flat year over year at $937 million, exceeding the Zacks Consensus Estimate of $910 million; on a constant-currency basis, revenues improved by 1.4% [4] - Direct-to-consumer (DTC) revenues increased by 2.3%, while wholesale revenues fell by 1.6%; on a constant-currency basis, DTC revenues jumped by 3.5% and wholesale revenues were flat [4] Brand Performance - Revenues for the Crocs brand grew by 2.4% year over year to $762 million, with a 1.1% increase in DTC revenues and a 3.2% rise in wholesale revenues; on a constant-currency basis, revenues improved by 4.2% [5] - HEYDUDE brand revenues rose by 9.8% year over year to $176 million, with a 17.9% decrease in wholesale revenues offset by an 8.3% increase in DTC revenues; on a constant-currency basis, revenues improved by 9.5% [6] Profitability Metrics - Adjusted gross profit rose by 3% year over year to $541.5 million, with adjusted gross margin expanding by 180 basis points to 57.8% [7] - Adjusted selling, general and administrative (SG&A) expenses increased by 520 basis points to 34% of revenues; adjusted operating income fell by 12.5% year over year to $255 million, with adjusted operating margin contracting by 330 basis points to 23.8% [7] Financial Position - At the end of Q1 2025, the company had cash and cash equivalents of $166.5 million, long-term borrowings of $1.48 billion, and stockholders' equity of $1.97 billion [8] - The company borrowed $130 million in debt during the quarter and repurchased 0.6 million shares for $61 million, with $1.3 billion of share repurchase authorization available for future repurchases [9] Outlook - Due to ongoing macroeconomic uncertainty, the company has withdrawn its 2025 financial guidance and will not issue an updated full-year outlook at this time [10]
BioHarvest Sciences Inc. (BHST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ZACKS· 2025-05-08 15:05
The market expects BioHarvest Sciences Inc. (BHST) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to ...
Gambling.com Group Limited (GAMB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2025-05-08 15:01
Core Viewpoint - The market anticipates Gambling.com Group Limited (GAMB) to report a year-over-year increase in earnings driven by higher revenues for the quarter ending March 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected on May 15, 2025, with a consensus EPS estimate of $0.25, reflecting a 25% year-over-year increase, and revenues projected at $40.38 million, a 38.2% increase from the previous year [3][2]. - A positive earnings surprise could lead to a stock price increase, while a miss may result in a decline [2]. Estimate Revisions - The consensus EPS estimate has been revised down by 1.61% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][10]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -25%, complicating predictions for an earnings beat [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likelihood of actual earnings deviating from consensus estimates, with positive readings being more predictive of earnings beats [5][7]. - Stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have historically shown a nearly 70% chance of delivering a positive surprise [8]. Historical Performance - Gambling.com has a history of beating consensus EPS estimates, having done so in the last four quarters, including a 40% surprise in the last reported quarter [12][13]. Conclusion - Despite the historical performance, Gambling.com does not currently appear to be a strong candidate for an earnings beat, and investors should consider other factors before making investment decisions [16].
Cava Group (CAVA) Earnings Expected to Grow: Should You Buy?
ZACKS· 2025-05-08 15:01
Wall Street expects a year-over-year increase in earnings on higher revenues when Cava Group (CAVA) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 15. On the ...
Knightscope, Inc. (KSCP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
ZACKS· 2025-05-08 15:01
Company Overview - Knightscope, Inc. (KSCP) is expected to report a year-over-year increase in earnings driven by higher revenues for the quarter ended March 2025, with a consensus estimate indicating a quarterly loss of $1.47 per share, reflecting a change of +63.3% year-over-year [1][3] - Revenues are projected to be $2.68 million, which represents a 19.1% increase from the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly reassessed their initial estimates [4] - The Most Accurate Estimate for Knightscope is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -11.95%, suggesting a bearish outlook from analysts [10] Historical Performance - In the last reported quarter, Knightscope was expected to post a loss of $1.88 per share but actually reported a loss of $0.78, resulting in a positive surprise of +58.51% [12] - Over the past four quarters, the company has only beaten consensus EPS estimates once [13] Industry Context - In the Zacks Technology Services industry, Bitfarms Ltd. (BITF) is expected to report a loss of $0.04 per share for the same quarter, indicating a year-over-year change of -100%, with revenues expected to be $65.47 million, up 30.1% from the previous year [17] - Bitfarms has seen a 16.7% downward revision in its consensus EPS estimate over the last 30 days, resulting in an Earnings ESP of -36.36% [18]
Flexible Solutions International Inc. (FSI) Earnings Expected to Grow: Should You Buy?
ZACKS· 2025-05-08 15:00
Company Overview - Flexible Solutions International Inc. (FSI) is expected to report a year-over-year increase in earnings, with a projected EPS of $0.05, reflecting a +25% change, and revenues anticipated at $10.2 million, up 10.5% from the previous year [3]. Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - The Most Accurate Estimate for FSI matches the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - FSI currently holds a Zacks Rank of 4 (Sell), complicating the prediction of an earnings beat [11]. Historical Performance - In the last reported quarter, FSI met the consensus EPS estimate of $0.05, resulting in no surprise [12]. - Over the past four quarters, FSI has only surpassed consensus EPS estimates once [13]. Industry Comparison - In the Zacks Chemical - Specialty industry, Hawkins (HWKN) is expected to post earnings of $0.74 per share, indicating a +12.1% year-over-year change, with revenues projected at $230.08 million, up 3.2% from the previous year [17].